Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

Stochastic optimal control to guide adaptive cancer therapy

MingYi Wang, View ORCID ProfileJacob G. Scott, View ORCID ProfileAlexander Vladimirsky
doi: https://doi.org/10.1101/2022.06.17.496649
MingYi Wang
1Center for Applied Mathematics, Cornell University, Ithaca, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jacob G. Scott
2Dept. of Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jacob G. Scott
Alexander Vladimirsky
3Dept. of Mathematics and Center for Applied Mathematics, Cornell University, Ithaca, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alexander Vladimirsky
  • For correspondence: vladimirsky@cornell.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

While adaptive cancer therapy is beginning to prove a promising approach of building evolutionary dynamics into therapeutic scheduling, the stochastic nature of cancer evolution has rarely been incorporated. Various sources of random perturbations can impact the evolution of heterogeneous tumors. In this paper, we propose a method that can effectively select optimal adaptive treatment policies under randomly evolving tumor dynamics based on Stochastic Optimal Control theory. We first construct a stochastic model of cancer dynamics under drug therapy based on Evolutionary Game theory. That model is then used to improve the cumulative ''cost'', a combination of the total amount of drugs used and the time to recovery. As this cost becomes random in a stochastic setting, we maximize the probability of recovery under a pre-specified cost threshold (or a ''budget''). We can achieve our goal for a range of threshold values simultaneously using the tools of dynamic programming. We then compare our threshold-aware policies with the policies previously shown to be optimal in the deterministic setting. We show that this threshold-awareness yields a significant improvement in the probability of under-the-budget recovery, which is correlated with a lower general drug usage. The particular model underlying our discussion has originated in [Kaznatcheev et al. 2017], but the presented approach is far more general and provides a new tool for optimizing adaptive therapies based on a broad range of stochastic cancer models.

Competing Interest Statement

The authors have declared no competing interest.

Footnotes

  • https://eikonal-equation.github.io/Stochastic-Cancer/

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted June 19, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Stochastic optimal control to guide adaptive cancer therapy
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Stochastic optimal control to guide adaptive cancer therapy
MingYi Wang, Jacob G. Scott, Alexander Vladimirsky
bioRxiv 2022.06.17.496649; doi: https://doi.org/10.1101/2022.06.17.496649
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Stochastic optimal control to guide adaptive cancer therapy
MingYi Wang, Jacob G. Scott, Alexander Vladimirsky
bioRxiv 2022.06.17.496649; doi: https://doi.org/10.1101/2022.06.17.496649

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Cancer Biology
Subject Areas
All Articles
  • Animal Behavior and Cognition (3584)
  • Biochemistry (7537)
  • Bioengineering (5494)
  • Bioinformatics (20723)
  • Biophysics (10279)
  • Cancer Biology (7946)
  • Cell Biology (11604)
  • Clinical Trials (138)
  • Developmental Biology (6577)
  • Ecology (10161)
  • Epidemiology (2065)
  • Evolutionary Biology (13572)
  • Genetics (9511)
  • Genomics (12811)
  • Immunology (7900)
  • Microbiology (19489)
  • Molecular Biology (7631)
  • Neuroscience (41961)
  • Paleontology (307)
  • Pathology (1254)
  • Pharmacology and Toxicology (2189)
  • Physiology (3258)
  • Plant Biology (7017)
  • Scientific Communication and Education (1293)
  • Synthetic Biology (1945)
  • Systems Biology (5416)
  • Zoology (1111)